Bionano Genomics
BNGO
55 hedge funds and large institutions have $5.61M invested in Bionano Genomics in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 20 closing their positions.
1,659% more call options, than puts
Call options by funds: $1.07M | Put options by funds: $61K
2.05% less ownership
Funds ownership: 11.3% → 9.25% (-2.1%)
11% less funds holding
Funds holding: 62 → 55 (-7)
14% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 14
35% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 20
54% less capital invested
Capital invested by funds: $12.3M → $5.61M (-$6.71M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$576K |
| 2 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$184K |
| 3 |
CA
Cetera Advisors
Denver,
Colorado
|
+$183K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$120K |
| 5 |
Jane Street
New York
|
+$111K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
-$1M |
| 2 |
Renaissance Technologies
New York
|
-$972K |
| 3 |
Two Sigma Investments
New York
|
-$770K |
| 4 |
CF
Cantor Fitzgerald
New York
|
-$750K |
| 5 |
Millennium Management
New York
|
-$371K |
BNGO Hedge Fund Activity: Q1 2024 in Review
55 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q1 2024, worth a combined $5.61M — down 54% from $12.3M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of BNGO and 13 opened new positions — a net loss of 7 holders — while 14 trimmed existing stakes and 12 added.
The largest buyer was GSA Capital Partners, adding an estimated $576K. The largest seller was GMT Capital, exiting entirely with an estimated $1M sold.
- 55 institutional investors held Bionano Genomics (BNGO) as of Q1 2024, down from 62 in Q4 2023.
- Funds reported $5.61M of Bionano Genomics stock for Q1 2024, down 54% quarter-over-quarter.
- 13 funds opened new Bionano Genomics positions in Q1 2024 and 20 closed out, a net change of -7 holders.
- The largest Bionano Genomics buyer in Q1 2024 was GSA Capital Partners, an estimated $576K added.
- The largest Bionano Genomics seller in Q1 2024 was GMT Capital, an estimated $1M sold.
Based on aggregated 13F filings for Q1 2024.